Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine.
Journal Information
Full Title: AIDS
Abbreviation: AIDS
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Acquired Immunodeficiency Syndrome
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest There are no conflicts of interest."
"They convey their thanks to the ANRS both for funding the PREVENIR study and for a research grant for SC, this support was essential to our achievements."
"Full inclusion and exclusion criteria for the ANRS PREVENIR trial are available at ClinicalTrials.gov NCT03113123 and EudraCT 2016A0157744. Prior to implementation, the sub-study protocol was reviewed and approved by the Institutional Review Board (Comité de Protection des Personnes) at Paris University IV and the French Drug Agency (Agence nationale de sécurité du medicament et des produits de santé). All participants provided written informed consent for the sub-study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025